January 8, 2024
RedChip Logo

RedChip Companies

Weekly Newsletter
 

Soligenix Announces Top-line Results of the Phase 2a Study of SGX302 (Synthetic Hypericin) in Patients with Mild-to-Moderate Psoriasis

Soligenix (Nasdaq: SNGX), a late-stage biopharmaceutical company focused on developing and commercializing products to treat rare diseases where there is an unmet medical need, announced preliminary top-line results of its ongoing Phase 2a trial of SGX302 (synthetic hypericin) for the treatment of mild-to-moderate psoriasis. In the expanded portion of the trial (Cohort 2), an additional five patients were enrolled and the treatment guidelines for use of light activation were adjusted to allow for a more rapid escalation and higher final dose level of light than in the initial cohort of patients, which is expected to more closely mirror the way the drug will eventually be used in a "real world" clinical setting.

For more information, visit www.soligenix.com

 
See More Info
 
 
 

American Resources Corporation's Affiliated Company, Novusterra Inc., Announces Strategic Partnership with Kenai Defense, Texas Tech University, and the United States Air Force

American Resources (Nasdaq: AREC), a next generation and socially responsible supplier of rare earth and critical elements, carbon and advanced carbon materials to the new infrastructure and electrification marketplace, announced that their affiliated company, Novusterra Inc. (Private) ("Novusterra") a company specializing in the development and production of carbon nanomaterials and graphene to the infrastructure, agriculture, and electrification economy, announced that its patented technology to produce carbon nanomaterial additives for concrete and asphalt pavements is being used as the exclusive patented technology in a comprehensive research project to improve the future durability of airfields for the United States Air Force.

 
Learn More
   

Everything Blockchain Inc. Launches EB Control Enterprise

Everything Blockchain (OTC: EBZT), a technology company that is blending blockchain, DBMS and Zero Trust to deliver disruptive new ways to store, manage and protect data, has launched EB Control Enterprise. Expanding upon the celebrated EB Control platform, EB Control Enterprise will feature an enhanced centralized management portal, empowering companies to perform comprehensive enterprise management and reporting on a larger scale. EB Control Enterprise now also plugs seamlessly into enterprise IT workflows such as Active Directory ADFS and adds support for FIDO 2 and SAML.

 
Learn More
 

Royalty Management Holding Corporation 2023 Year End Shareholder Letter

Royalty Management (Nasdaq: RMCO), an innovative royalty company building shareholder value by acquiring and developing high value assets in a sustainable market environment, provided its shareholders with its year-end 2023 business and Company update.

 
Learn More
 

Zomedica Announces Publication of Research Validating Better Patient Acceptance of PulseVet(R) Electro-hydraulic Shock Wave Therapy without Sedation Utilizing Novel “X-Trode” Handpiece

Zomedica (NYSE American: ZOM), a veterinary health company offering point-of-care diagnostics and therapeutic products for equine and companion animals, announced the publication of an article validating the ability to better utilize PulseVet electro-hydraulic shock wave therapy in canine patients without sedation.

 
Learn More
 

 
 

Small Stocks Big Money™ Podcasts

Available on:


 
Learn More
 
 
 

Upcoming Events

9

January

2024

NASDAQ: BIAF - bioAffinity Technologies
4:15pm Eastern
bioAffinity Technologies addresses the urgent need for noninvasive, accurate early-stage cancer diagnosis and broad-spectrum cancer treatments.
 
Sign Up
 

10

January

2024

NASDAQ: SPI - SPI Energy
4:15pm Eastern
SPI Energy is a global renewable energy company and provider of solar storage and electric vehicle (EV) solutions that was founded in 2006 in Roseville, California and is headquartered in McClellan Park, California.
 
Sign Up
 

11

January

2024

NASDAQ: ASPI - ASP Isotopes
4:15pm Eastern
ASP Isotopes is an isotope enrichment company utilizing technology developed in South Africa over the past 20 years to enrich isotopes of elements or molecules with low atomic masses.
 
Sign Up
 
 
 

Archive Events

20

December

2023

NASDAQ: RVPH - Reviva Pharmaceuticals
Meeting Duration 45 minutes
Reviva is a Phase 3 clinical-stage biopharmaceutical company that discovers, develops and seeks to commercialize next-generation therapeutics for diseases representing unmet medical needs and burdens to society, patients, and their families.
 
Watch Replay
 
 
 

Lesson of the Week

Mitigate Risk by Buying Small-Caps in Bunches

 
Learn More
 
 
 
 

RedChip TV

BioVie (NASDAQ:BIVI): Transformative Therapies for Neurodegeneration

 
 

MidSouth Week in Review

Gold hit 2089 from its recent 1996 level. The 30-year bond yield dropped below 4% from its recent 5%+ level.

 
Learn More
 

You are receiving this email because your email is subscribed to our mailing list.
Click here to update your subscription or unsubscribe your email address.
Copyright © 2024 Redchip Companies, Inc. All rights reserved.
© 2024 Redchip Companies, Inc. All rights reserved